meglumine antimoniate has been researched along with antimony sodium gluconate in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (19.70) | 18.7374 |
1990's | 17 (25.76) | 18.2507 |
2000's | 20 (30.30) | 29.6817 |
2010's | 12 (18.18) | 24.3611 |
2020's | 4 (6.06) | 2.80 |
Authors | Studies |
---|---|
Franke, ED; Grogl, M; Thomason, TN | 1 |
Abahussain, A; al-Gindan, Y; alKhawajah, A; Jain, S; Larbi, EB | 1 |
Croft, SL; Frommel, D; Gebre-Hiwot, A; Tadesse, G | 1 |
Jennings, FW | 1 |
Ellis, WY; Jackson, JE; Lawyer, PG; Limmer, BL; Mebrahtu, YB; Panisko, DM; Reed, SG; Tally, JD; Were, JB | 1 |
Vion, B | 1 |
Jackson, JE; Tally, JD; Tang, DB | 1 |
de Vásquez, AM; Johnson, CM; Narvaez, E; Paz, HM; Sáenz, RE | 1 |
Chulay, JD; Fleckenstein, L; Smith, DH | 1 |
Carvalho, EM; Costa, JL; Llanos-Cuentas, EA; Marsden, PD; Sampaio, RN; Veiga, JP | 1 |
Anciaux, ML; Bourée, P; Taugourdeau, P | 1 |
Tsetentis, Y | 1 |
Chong, H | 1 |
Marsden, PD | 1 |
Marsden, PD; Sampaio, RN; Veiga, JP; Wolff, ER | 1 |
Steck, EA | 1 |
Fisher, BK; Schewach-Millet, M; Semah, D | 1 |
Matthews, PJ; Neal, RA | 1 |
Berman, JD; Franke, ED; Gasser, RA; Grögl, M; Magill, AJ; Oster, CN | 1 |
Buffet, P; Caumes, E; Gentilini, M | 1 |
Cortés, E; Cucurull, E; de Otero, J; Ocaña, I; Pahissa, A; Ribera, E | 1 |
Barbosa, AC; Dorea, JG; Franco, MA; Rath, S | 1 |
Ali, A; Berhe, N; Hailu, A; Yeneneh, H | 1 |
Evans, TG | 1 |
Cortes, E; de Otero, J; Gasser, I; Ocaña, I; Pahissa, A; Ribera, E | 1 |
Abdo, MC; Anacleto, C; Fernandes, AP; Ferreira-Pinto, KC; Miranda-Vilela, AL; Moreira, ES; Petrillo-Peixoto, ML | 1 |
Gilead, L; Horev, L; Jonas, F; Klaus, SN; Zlotogorski, A | 1 |
Bitnun, A; Ephros, M; Shaked, P; Waldman, E; Zilberstein, D | 1 |
Dumon, H; Faraut-Gambarelli, F; Garnier, JM; Gire, C; Minodier, P; Piarroux, R | 1 |
Davidson, RN | 1 |
Hepburn, NC | 1 |
Delgado, G; Moreno, A; Patarroyo, ME; Puentes, F | 1 |
Kafetzis, DA; Maltezou, HC | 1 |
Abebe, Y; Abraham, Y; Ali, A; Berhe, N; Hailu, A; Mengistu, G; Tsige, K | 1 |
Garnier, JM; Horelt, A; Minodier, P; Retornaz, K | 1 |
Enk, CD; Gardlo, K; Hochberg, M; Ingber, A; Ruzicka, T | 1 |
Amini Harandi, A; Asilian, A; Faghihi, G; Momeni, A; Sadeghinia, A | 1 |
Cardenas, GA; Cohen, C; Gonzalez-Serva, A | 1 |
Garnier, JM; Minodier, P; Retornaz, K; Robert, S | 1 |
Querido, J | 1 |
Saravia, NG; Walker, J | 1 |
Cardoso, JE; de Oliveira-Silva, F; Fernandes, AP; Ferreira, LA; Gonçalves, GS; Maciel, FC; Rabello, A; Souza, RC | 1 |
Gómez, A; Henao, HH; Osorio, Y; Saravia, NG; Travi, B | 1 |
Dugas, B; Mazier, D; Pino, P; Rougier, S; Vouldoukis, I; Woehrlé, F | 1 |
Bermúdez, H; Boelaert, M; Chappuis, F; Desjeux, P; Dujardin, JC; Garcia, L; Rojas, E | 1 |
Blanc, P; Garnier, JM; Minodier, P; Noël, G; Retornaz, K; Uters, M | 1 |
Brooker, S; Chappuis, F; Kabatereine, N; Kolaczinski, JH; Onapa, A; Reithinger, R; Worku, DT | 1 |
Boucher, P; Hadighi, R; Khamesipour, A; Meamar, AR; Mohebali, M; Ouellette, M; Roy, G | 1 |
Amato Neto, V; Amato, VS; Graf, ME; Nicodemo, AC; Siqueira, AM; Tuon, FF | 1 |
Boutaleb-Charki, S; Díaz, JG; Guitierrez-Sánchez, R; Huertas, O; Marín, C; Pérez-Cordon, G; Rosales, MJ; Sánchez-Moreno, M | 1 |
Abreu, KL; Daher, EF; Franco, LF; Garcia, AV; Libório, AB; Mota, RM; Oliveira, MJ; Rocha, NA; Silva Júnior, GB | 1 |
Demicheli, C; Frézard, F | 1 |
Chakravarty, J; Sundar, S | 1 |
Coelho, DR; De-Carvalho, RR; Paumgartten, FJ; Rocha, RC; Saint'Pierre, TD | 1 |
Bhattacharjee, H; Charret, KS; Mandal, G; Mandal, S; Mukhopadhyay, R; Papadopoulou, B; Sharma, M | 1 |
Awan, MM; Jamal, Q; Khan, NH; Shah, A; Sutherland, C; Wahid, S | 1 |
Aksoy, M; Ardic, N; Oghumu, S; Satoskar, AR; Surucu, HA; Yesilova, A; Yesilova, Y | 1 |
Andrade Junior, HF; Borborema, SE; Nascimento, Nd; Osso Junior, JA | 1 |
Brito, NC; Cota, GF; Rabello, A | 1 |
Çavuş, İ; Ertabaklar, H; Kaya, T; Özbilgin, A; Yıldırım, A | 1 |
Eid Rodríguez, D; Pulkki-Brännström, AM; San Sebastian, M | 1 |
Çavuş, İ; Harman, M; Kaya, T; Özbilgin, A; Yıldırım, A | 1 |
Al-Mohammed, HI; Seif, MA | 1 |
Almani, PGN; Bamorovat, M; Salari, S; Sharifi, I | 1 |
Friedman, A; Siewe, N | 1 |
18 review(s) available for meglumine antimoniate and antimony sodium gluconate
Article | Year |
---|---|
Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis.
Topics: Allopurinol; Aminoquinolines; Antimony; Antimony Sodium Gluconate; Cryosurgery; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Levamisole; Liposomes; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Phenothiazines; Rifampin | 1986 |
Mucosal leishmaniasis ("espundia" Escomel, 1911).
Topics: Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Granuloma; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
The chemotherapy of protozoal infections: whither?
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Models, Animal; Glycolipids; Humans; Leishmaniasis; Leishmaniasis, Visceral; Liposomes; Lysosomes; Malaria; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Primaquine; Protozoan Infections; Trypanosomiasis | 1981 |
[Treatment of localized cutaneous leishmaniasis].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1994 |
Leishmaniasis.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Child, Preschool; Female; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Vaccines; Vaccination | 1993 |
[Treatment of infantile visceral leishmaniasis].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Drug Resistance; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors; Treatment Outcome | 1999 |
Visceral leishmaniasis in clinical practice.
Topics: AIDS-Related Opportunistic Infections; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Female; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1999 |
Cutaneous leishmaniasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Life Cycle Stages; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence; Skin | 2000 |
Visceral leishmaniasis in paediatrics.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Child; Disease Vectors; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence | 2002 |
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Treatment Failure | 2003 |
[Cutaneous leishmaniasis].
Topics: Amphotericin B; Anti-Bacterial Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Controlled Clinical Trials as Topic; Diagnosis, Differential; Double-Blind Method; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Photochemotherapy; Time Factors | 2003 |
[Visceral leishmaniasis: new drugs].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2003 |
[Treatment of visceral leishmaniasis in children].
Topics: Amphotericin B; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2007 |
Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Developing Countries; Endemic Diseases; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Pentamidine | 2008 |
New delivery strategies for the old pentavalent antimonial drugs.
Topics: Administration, Oral; Administration, Topical; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Delivery Systems; Humans; Leishmaniasis; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2010 |
Leishmaniasis: an update of current pharmacotherapy.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Practice Guidelines as Topic; Species Specificity; Treatment Outcome | 2013 |
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cryotherapy; Databases, Factual; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2017 |
Global distribution of treatment resistance gene markers for leishmaniasis.
Topics: Antimony Sodium Gluconate; Antiprotozoal Agents; Biomarkers; Drug Resistance; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine Antimoniate | 2022 |
1 trial(s) available for meglumine antimoniate and antimony sodium gluconate
Article | Year |
---|---|
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
Topics: Adult; Aged; Allopurinol; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Data Interpretation, Statistical; Female; Follow-Up Studies; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Multivariate Analysis; Organometallic Compounds; Recurrence; Retrospective Studies; Time Factors | 1996 |
47 other study(ies) available for meglumine antimoniate and antimony sodium gluconate
Article | Year |
---|---|
Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
Subacute toxicity of pentavalent antimony compounds in rats.
Topics: Alkaline Phosphatase; Animals; Antimony; Antimony Sodium Gluconate; Behavior, Animal; Bilirubin; Blood Cell Count; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Female; Hemoglobins; Kidney; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rats; Weight Gain | 1992 |
An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Evaluation, Preclinical; Humans; Leishmania; Leishmania donovani; Leukemia, Monocytic, Acute; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Pentamidine; Species Specificity; Tumor Cells, Cultured | 1992 |
Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO).
Topics: Animals; Antimony; Antimony Sodium Gluconate; Drug Synergism; Drug Therapy, Combination; Eflornithine; Female; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Succimer; Tartrates; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy.
Topics: Adenosine; Animals; Antimony Sodium Gluconate; Drug Resistance; Eflornithine; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1990 |
[Cutaneous leishmaniasis].
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1989 |
An in vitro micromethod for drug sensitivity testing of Leishmania.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Culture Media; Gluconates; Humans; Least-Squares Analysis; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Sorbitol; Time Factors | 1989 |
[Evaluation of the effectiveness and toxicity of pentostam and glucantime in the treatment of cutaneous leishmaniasis].
Topics: Adult; Antimony Sodium Gluconate; Drug Evaluation; Female; Gluconates; Humans; Immunologic Techniques; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Random Allocation; Sorbitol | 1987 |
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Gluconates; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis.
Topics: Adult; Amphotericin B; Antimony; Antimony Sodium Gluconate; Child; Gluconates; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Topics: Adolescent; Adult; Antimony; Antimony Sodium Gluconate; Child; Child, Preschool; Female; Gluconates; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Splenectomy | 1985 |
[Treatment of visceral leishmaniasis].
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance, Microbial; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Pentamidine | 1985 |
Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials.
Topics: Adult; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Gluconates; Humans; Kidney Diseases; Kidney Tubules; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1983 |
Leishmaniasis recidivans treated with sodium stibogluconate.
Topics: Adult; Anti-Bacterial Agents; Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence | 1981 |
In vivo antileishmanial properties of pentavalent antimonial compounds.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Gluconates; Leishmania; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred Strains; Organometallic Compounds | 1982 |
Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.
Topics: Adult; Amylases; Antimony Sodium Gluconate; Antiprotozoal Agents; District of Columbia; Humans; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Peru; Prospective Studies | 1994 |
[Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Enzyme Tests; Female; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence | 1995 |
Antimony oxidation states in antileishmanial drugs.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Stability; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxidation-Reduction | 1995 |
Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation.
Topics: Adolescent; Adult; Age Factors; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Ethiopia; Female; Follow-Up Studies; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Sex Factors; Treatment Outcome | 1994 |
Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines.
Topics: Animals; Antimony; Antimony Potassium Tartrate; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenates; ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA, Protozoan; Drug Resistance; Drug Resistance, Multiple; Gene Dosage; Genes, Protozoan; Leishmania; Leishmania guyanensis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxides; Puromycin; Sequence Homology, Nucleic Acid; Vinblastine | 1996 |
South American cutaneous leishmaniasis: report of ten cases in Israeli travelers.
Topics: Adult; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Headache; Humans; Israel; Leg Ulcer; Leishmania mexicana; Leishmaniasis, Cutaneous; Liver; Liver Function Tests; Male; Meglumine; Meglumine Antimoniate; Muscle Weakness; Muscular Diseases; Organometallic Compounds; Pain; Retrospective Studies; Skin; South America; Travel; Weight Loss | 1998 |
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenites; Drug Resistance, Multiple; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1999 |
Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Flow Cytometry; Humans; Leishmania guyanensis; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Propidium; Sensitivity and Specificity | 2001 |
Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis.
Topics: Adolescent; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Bradycardia; Child; Electrocardiography; Ethiopia; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2001 |
The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
Topics: Adolescent; Adult; Aged; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome | 2003 |
Multiple leg ulcers in a traveler.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Azure Stains; Biopsy; Humans; Leg Ulcer; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Travel | 2004 |
Emergency initiative to reduce leishmaniasis in Afghanistan.
Topics: Afghanistan; Antimony Sodium Gluconate; Antiprotozoal Agents; Bedding and Linens; Emergency Medical Services; Health Education; Humans; Incidence; International Cooperation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pesticides; Refugees | 2004 |
Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
Topics: Animals; Antimony; Antimony Potassium Tartrate; Antimony Sodium Gluconate; Antiprotozoal Agents; Benzimidazoles; Bisbenzimidazole; Camptothecin; Cell Survival; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Leishmania donovani; Meglumine; Meglumine Antimoniate; Monocytes; Organometallic Compounds; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; U937 Cells | 2004 |
Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Topics: Administration, Topical; Animals; Antimony Sodium Gluconate; Cricetinae; Female; Gels; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Paromomycin; Random Allocation; Statistics, Nonparametric | 2005 |
[Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2004 |
Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fluoroquinolones; Interleukin-6; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Nitric Oxide; Organometallic Compounds; Parasitic Sensitivity Tests; Quinolones; Tumor Necrosis Factor-alpha | 2006 |
Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
Topics: Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Bolivia; Drugs, Generic; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2006 |
Kala-azar control, Uganda.
Topics: Adolescent; Agglutination Tests; Animals; Antibodies, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Injections, Intramuscular; Isoptera; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Reagent Kits, Diagnostic; Risk Factors; Seroepidemiologic Studies; Travel; Uganda | 2007 |
Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine | 2007 |
Antileishmaniasis activity of flavonoids from Consolida oliveriana.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Flavonoids; Galactosides; Kaempferols; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Molecular Structure; Organometallic Compounds; Ranunculaceae; Rats; Rats, Inbred Strains; Turkey | 2009 |
Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Kidney Diseases; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Young Adult | 2010 |
Effects of in utero and lactational exposure to SbV on rat neurobehavioral development and fertility.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Estrus; Female; Fertility; Fetus; Lactation; Male; Meglumine; Meglumine Antimoniate; Milk; Motor Activity; Organometallic Compounds; Pregnancy; Rats; Rats, Wistar | 2014 |
Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
Topics: 3' Untranslated Regions; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Aquaglyceroporins; Aquaporin 1; Cell Movement; Drug Resistance; Gene Expression Regulation; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; RNA, Messenger; RNA, Protozoan | 2015 |
In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Line, Tumor; Child; Humans; Inhibitory Concentration 50; Leishmania tropica; Leishmaniasis, Cutaneous; Macrophages; Male; Meglumine; Meglumine Antimoniate; Naphthoquinones; Organometallic Compounds; Pakistan; Parasitic Sensitivity Tests | 2015 |
Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Young Adult | 2016 |
Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cricetinae; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Leishmania infantum; Liposomes; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphatidylserines | 2016 |
Control of visceral leishmaniasis in Somalia: achievements in a challenging scenario, 2013–2015.
Topics: Age Distribution; Ambulatory Care Facilities; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Incidence; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sex Distribution; Somalia | 2017 |
Evaluation of In vitro and In vivo Drug Efficacy Over Leishmania tropica: A Pilot Study.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Microbial Sensitivity Tests; Organometallic Compounds; Pilot Projects; Practice Guidelines as Topic; Turkey | 2018 |
"Cheaper and better": Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia.
Topics: Antimony Sodium Gluconate; Antiprotozoal Agents; Bolivia; Budgets; Cost Savings; Cost-Benefit Analysis; Drug Costs; Health Care Costs; Humans; Leishmaniasis, Cutaneous; Meglumine Antimoniate | 2019 |
Comparison of
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Female; Genotyping Techniques; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Paromomycin; Phosphorylcholine; Real-Time Polymerase Chain Reaction; Turkey | 2020 |
ASSESSMENT OF THE OXIDATIVE AND NITROSATIVE STRESS IN THE SERUM OF SAUDI PATIENTS WITH CUTANEOUS LEISHMANIASIS BEFORE AND AFTER TREATMENT.
Topics: Antimony Sodium Gluconate; Antiprotozoal Agents; Case-Control Studies; Humans; Leishmaniasis, Cutaneous; Macrophages; Male; Meglumine Antimoniate; Nitrosative Stress; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species | 2021 |
Treatment of leishmaniasis with chemotherapy and vaccine: a mathematical model.
Topics: Antimony Sodium Gluconate; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Models, Biological; Vaccines | 2023 |